As fears mount over J&J and AstraZeneca, Novavax enters a shaky spotlight

As fears mount over J&J and AstraZeneca, Novavax enters a shaky spotlight

Submitted by admin on April 21, 2021 - 11:20pm
Source: 
Endpoints
News Tags: 
JNJ
AstraZeneca
Novavax
vaccines
COVID-19
Headline: 
As fears mount over J&J and AstraZeneca, Novavax enters a shaky spotlight
snippet: 

As concerns rise around the J&J and AstraZeneca vaccines, global attention is increasingly turning to the little, 33-year-old, productless, bankruptcy-flirting biotech that could: Novavax.

Do Not Allow Advertisers to Use My Personal information